Document is current
Any future updates will be listed below
-
Authors
Galanaud, Jean-Philippe
Trujillo-Santos, Javier
Bikdeli, Behnood
Di Micco, Pierpaolo
Bortoluzzi, Cristiano
Bertoletti, Laurent
Pedrajas, José María
Ballaz, Aitor
Alfonso, Joaquín
Monreal, Manuel
,
-
Funding
Funding for this research was provided by:
Sanofi España
- License Information
-
More Information
Article History
Accepted: 16 November 2020
First Online: 28 November 2020
Compliance with ethical standards
:
: Dr Galanaud received research grants from Bayer and Leo-Pharma and consultant fees from BMS-Pfizer, Sanofi and Servier. Dr Bertoletti reports grants, personal fees and non-financial support from ACTELION, grants, personal fees and non-financial support from BAYER, grants, personal fees and non-financial support from BMS, grants, personal fees and non-financial support from PFIZER, grants, personal fees and non-financial support from MSD, non-financial support from DAICHII-SANKYO, personal fees and non-financial support from LEO-PHARMA, during the conduct of the study; Other authors have no conflicts to disclose.
